Top news
All coverage
Extra Shots from J. & J. and Pfizer Give Immune Boost, Companies Report (Published 2021)
By Sharon LaFraniere & Carl Zimmer
FDA Delays Carry a Death Toll
By Conor Friedersdorf
Heart inflammation risk boosted slightly by vaccine, more by COVID-19 -study
By Manojna Maddipatla
Full FDA approval of Pfizer vaccine opens door for vaccine mandates in Texas
By Joshua Fechter & Patrick Svitek
FDA cautions against off-label use of Pfizer/BioNTech Covid-19 vaccine in younger children
By Jacqueline Howard
FDA Grants Full Approval, Changes Name of Pfizer Vaccine
By Chaunie Marie Brusie
You asked, we answered: Are Pfizer's Comirnaty and BioNTech COVID-19 vaccines the same or different?
Vaccine hesitancy unlikely to disappear because of FDA approval
By Phil McCausland & Erik Ortiz
U.S. plans COVID-19 booster shots at six months instead of eight - WSJ
By Arun Koyyur & Manojna Maddipatla
Myocarditis More Common After Covid Vaccination, Study Finds
By Emily Anthes & Noah Mercer Weiland
Timelines for F.D.A. Approval for Moderna and J.&J. Vaccines Remain Unclear
By Daniel E. Slotnik
F.D.A. Fully Approves Pfizer Vaccine
By Sharon LaFraniere & Noah Mercer Weiland